2024 -now Non-clinical and Translational Science Consultant @
2024 -now Proprietor @ Triple Point Consulting
2024 -2026 Principal Scientist @
2021 -2024 Senior Scientist @
2021 -2021 Research Development Coordinator @
2020 -2021 Associate Lecturer @
2016 -2020 Associate Research Fellow @
2013 -2017 PhD Candidate @
2012 -2013 Research Assistant @
2013 -2013 Laboratory Demonstrator @
Benjamin Buckley Education
Monash University
Graduate Certificate of Biomedical Science and Commercialisation (Biological and Biomedical Sciences)
2021-2021
University of Wollongong
Doctor of Philosophy (PhD) (Medicinal Chemistry)
2013-2017
University of Wollongong
Bachelor of Biotechnology (Advanced) Hons I (Medicinal Chemstry)
2009-2012
Benjamin Buckley Summary
Benjamin Buckley, based in Sydney, NSW, AU, is currently a CEO at EpiAxis Therapeutics. Benjamin Buckley brings experience from previous roles at Adnovate Clinical, Triple Point Consulting, HaemaLogiX Ltd and Race Oncology. Benjamin Buckley holds a 2021 - 2021 Graduate Certificate of Biomedical Science and Commercialisation in Biological and Biomedical Sciences @ Monash University. Benjamin Buckley has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.